OTCMKTS:CELZ - Creative Medical Technology Stock Price, News, & Analysis

$0.0045
0.00 (0.00 %)
(As of 07/18/2019 06:00 AM ET)
Today's Range
$0.0032
Now: $0.0045
$0.0049
50-Day Range N/A
52-Week Range
$0.0024
Now: $0.0045
$0.0570
Volume16.85 million shs
Average Volume9.68 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Creative Medical Technology Holdings, Inc., through its subsidiaries, engages in the stem cell research and developing applications to treat male sexual dysfunction and related issues. The company markets its erectile dysfunction (ED) treatment under the Caverstem name to physicians for use with their patients suffering from ED. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona. Creative Medical Technology Holdings, Inc. is a subsidiary of Creative Medical Health, Inc.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CELZ
CUSIPN/A
Phone+1-602-6807439

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CELZ News and Ratings via Email

Sign-up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter.

Creative Medical Technology (OTCMKTS:CELZ) Frequently Asked Questions

What is Creative Medical Technology's stock symbol?

Creative Medical Technology trades on the OTCMKTS under the ticker symbol "CELZ."

Has Creative Medical Technology been receiving favorable news coverage?

News articles about CELZ stock have been trending somewhat negative recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Creative Medical Technology earned a news impact score of -1.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Creative Medical Technology.

Who are some of Creative Medical Technology's key competitors?

What other stocks do shareholders of Creative Medical Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Creative Medical Technology investors own include Chinanet Online (CNET), Knight-Swift Transportation (KNX), Camber Energy (CEI), CV Sciences (CVSI), Blink Charging (BLNK), Abraxas Petroleum (AXAS), Antares Pharma (ATRS), Arsanis (ASNS), Digital Turbine (APPS) and Oilex (OEX).

Who are Creative Medical Technology's key executives?

Creative Medical Technology's management team includes the folowing people:
  • Mr. Timothy Warbington, Chairman, Pres & CEO (Age 57)
  • Dr. Amit N. Patel, Founder & Director (Age 46)
  • Mr. Donald Dickerson, Sr. VP, CFO & Director (Age 54)
  • Dr. Thomas E. Ichim, Chief Scientific Officer & Director (Age 43)
  • Mr. Gary Mells, VP of Sales

How do I buy shares of Creative Medical Technology?

Shares of CELZ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Creative Medical Technology's stock price today?

One share of CELZ stock can currently be purchased for approximately $0.0045.

What is Creative Medical Technology's official website?

The official website for Creative Medical Technology is http://www.creativemedicaltechnology.com/.

How can I contact Creative Medical Technology?

Creative Medical Technology's mailing address is 2017 W Peoria Ave, PHOENIX, AZ 85029-4916, United States. The company can be reached via phone at +1-602-6807439.


MarketBeat Community Rating for Creative Medical Technology (OTCMKTS CELZ)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  55 (Vote Outperform)
Underperform Votes:  56 (Vote Underperform)
Total Votes:  111
MarketBeat's community ratings are surveys of what our community members think about Creative Medical Technology and other stocks. Vote "Outperform" if you believe CELZ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CELZ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2019 by MarketBeat.com Staff

Featured Article: Market Perform

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel